Gentry PR - Search Results

1

Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalate.

Gentry PR, Clewell HJ 3rd, Clewell R, Campbell J, Van Landingham C, Shipp AM. Gentry PR, et al. Crit Rev Toxicol. 2011 Aug;41 Suppl 2:1-72. doi: 10.3109/10408444.2011.599366. Crit Rev Toxicol. 2011. PMID: 21838516 Review.

2

Evaluation of physiologically based pharmacokinetic models in risk assessment: an example with perchloroethylene.

Clewell HJ, Gentry PR, Kester JE, Andersen ME. Clewell HJ, et al. Among authors: gentry pr. Crit Rev Toxicol. 2005 Jun;35(5):413-33. doi: 10.1080/10408440590931994. Crit Rev Toxicol. 2005. PMID: 16097137 Review.

3

Formaldehyde exposure and leukemia: critical review and reevaluation of the results from a study that is the focus for evidence of biological plausibility.

Gentry PR, Rodricks JV, Turnbull D, Bachand A, Van Landingham C, Shipp AM, Albertini RJ, Irons R. Gentry PR, et al. Crit Rev Toxicol. 2013 Sep;43(8):661-70. doi: 10.3109/10408444.2013.818618. Epub 2013 Jul 31. Crit Rev Toxicol. 2013. PMID: 23902349 Review.

4

The impact of recent advances in research on arsenic cancer risk assessment.

Gentry PR, Clewell HJ 3rd, Greene TB, Franzen AC, Yager JW. Gentry PR, et al. Regul Toxicol Pharmacol. 2014 Jun;69(1):91-104. doi: 10.1016/j.yrtph.2014.02.006. Epub 2014 Feb 15. Regul Toxicol Pharmacol. 2014. PMID: 24534001

5

Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic.

Gentry PR, Yager JW, Clewell RA, Clewell HJ 3rd. Gentry PR, et al. Toxicol In Vitro. 2014 Oct;28(7):1196-205. doi: 10.1016/j.tiv.2014.05.011. Epub 2014 Jun 14. Toxicol In Vitro. 2014. PMID: 24937311

6

An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion.

Gentry PR, Hack CE, Haber L, Maier A, Clewell HJ 3rd. Gentry PR, et al. Toxicol Sci. 2002 Nov;70(1):120-39. doi: 10.1093/toxsci/70.1.120. Toxicol Sci. 2002. PMID: 12388841

7

Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation.

Gentry PR, Covington TR, Clewell HJ 3rd. Gentry PR, et al. Regul Toxicol Pharmacol. 2003 Aug;38(1):1-16. doi: 10.1016/s0273-2300(03)00047-3. Regul Toxicol Pharmacol. 2003. PMID: 12878049

8

Application of a physiologically based pharmacokinetic model for reference dose and reference concentration estimation for acetone.

Gentry PR, Covington TR, Clewell HJ 3rd, Anderson ME. Gentry PR, et al. J Toxicol Environ Health A. 2003 Dec 12;66(23):2209-25. doi: 10.1080/713853996. J Toxicol Environ Health A. 2003. PMID: 14612334

9

Physiologically based pharmacokinetic modeling of arsenic in the mouse.

Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ 3rd. Gentry PR, et al. J Toxicol Environ Health A. 2004 Jan 9;67(1):43-71. doi: 10.1080/15287390490253660. J Toxicol Environ Health A. 2004. PMID: 14668111

10

Comparison of tissue dosimetry in the mouse following chronic exposure to arsenic compounds.

Gentry PR, Covington TR, Lawrence G, McDonald T, Snow ET, Germolec D, Moser G, Yager JW, Clewell HJ 3rd. Gentry PR, et al. J Toxicol Environ Health A. 2005 Mar 12;68(5):329-51. doi: 10.1080/15287390590900813. J Toxicol Environ Health A. 2005. PMID: 15799626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters